← All trials
NCT04768179
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 19, 2021
- Primary completion
- Jun 30, 2021
- Completion date
- Sep 30, 2021
- First posted
- Feb 24, 2021
- Last posted
- Feb 24, 2021
- Enrollment
- 490
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Makerere UniversityLead sponsor
- Joint Clinical Research Centre, Kampala, UgandaCollaborator
- Mbarara University of Science and TechnologyCollaborator
- Makerere UniversityReponsible party - principal investigator
- Government of UgandaCollaborator
- Makerere UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.